Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 540797 | NSE Symbol : SHALBY | ISIN : INE597J01018 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
28-Jan-2025	03-Feb-2025	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31 2024 and other business matters The Board Meeting to be held on 03/02/2025 has been revised to 03/02/2025 The Board Meeting to be held on 03/02/2025 has been revised to 03/02/2025 (As Per BSE Announcement Dated on: 28/01/2025) Unaudited Standalone and Consolidated Financial results for quarter ended December 31, 2024 (As Per Bse Announcement Dated on 03.02.2025)
23-Oct-2024	30-Oct-2024	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve unaudited standalone and consolidated financial results for quarter and half year 30th September 2024 and other business matters Outcome of Board meeting (As Per BSE Announcement Dated on 30.10.2024)
29-Jun-2024	08-Jul-2024	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/07/2024 inter alia to consider and approve unaudited financial results for quarter ended June 30 2024 Outcome of Board Meeting Q1FY2024-25 Results-Unaudited Financials results For Q1FY2024-25 (As per BSE Announcement Dated on 08/07/2024)
17-May-2024	28-May-2024	Final Dividend	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for quarter and year ended March 31 2024 and recommendation of dividend for FY 2023-24 BM-Recommendation of Dividend (As Per BSE Announcement dated on 28.05.2024)
12-Mar-2024	12-Mar-2024	Acquisitions	Acquisition of 100% equity shares of Healers Hospital Private Limited Update on acquisition of 100% Equity Stake in Healers Hospital Private Limited (As Per BSE Announcement Dated on 16.03.2024)
30-Jan-2024	07-Feb-2024	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve Unaudited Standalone and Consolidated financial results for quarter ended December 31 2023 and other business matters Financial results Q3 FY 2023-24 Unaudited standalone and consolidated Financial Results for quarter ended December 31, 2023 (As Per BSE Announcement dated on 07.02.2024)
18-Jan-2024	18-Jan-2024	Acquisitions	Outcome of Board Meeting held on January 18, 2024 - Acquisition
19-Oct-2023	27-Oct-2023	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve Unaudited Standalone And Consolidated Financial Results For Quarter Ended September 30 2023 Financial Results for Quarter and Half Year ended September 30, 2023 Outcome of Board Meeting - Financial Results For Quarter and Half Year Ended September 30, 2023 (As Per BSE Announcement dated on 27.10.2023)
13-Jul-2023	20-Jul-2023	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial results for quarter ended June 30 2023 and other business matters Financial Results for quarter ended June 30, 2023 Outcome of Board Meeting for unaudited Financial Results for Quarter ended June 30, 2023 (As Per BSE Announcement Dated on 20.07.2023)
05-May-2023	18-May-2023	Accounts	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2023 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for quarter and year ended March 31 2023 recommendation of dividend for FY2022-23 and other business matters Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 ,inter alia, to consider and approve Audited financial results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2023, recommendation of dividend on equity shares for year ended March 31, 2023 and other business matters. (As Per BSE Announcement Dated on 09.05.2023) Audited Financial Results for FY 2022-23 Board recommended of Rs. 1.20 per equity share of Rs. 10/- each for financial year 2022-23 Outcome of Board Meeting held on 18th May 2023 Appointment of Mr. Ashok Bhatia and Mr. Vijay Kedia as Non-Executive and Independent Directors, subject to approval of members at the ensuing Annual General Meeting Appointment of Mr. Amit Pathak, as Chief Financial Officer w.e.f. May 19, 2023 Re-appointment of Statutory Auditors for second term of 5 years, subject to approval of members at ensuing annual general meeting (As Per BSE Announcement Dated on 18/05/2023)
05-Jan-2023	17-Jan-2023	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for quarter ended December 31 2022. Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('the SEBI LODR') (As Per BSE Announcement dated on 17.01.2023)
20-Dec-2022	20-Dec-2022	Subsidiary Company	Conversion of Loan given by Mars Medical Devices Limited (MMDL) (WOS of Shalby Ltd) to Shalby Advanced Technologies, Inc. USA (WOS of MMDL) into Preferred Stock and Common Stock
11-Oct-2022	18-Oct-2022	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2022 inter alia to consider and approve financial statements for quarter and half year ended September 2022 - Intimation under regulation 29(1) of SEBI (LODR) Reg 2015. Outcome of Board Meeting held on 18-Oct-2022 for approval of standalone and consolidated financial statements for the quarter and half year ended September 30, 2022 (As per BSE Announcement Dated on 18/10/2022)
18-Jul-2022	26-Jul-2022	Quarterly Results	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2022 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results for quarter ended June 30 2022. Considered and Approved Unaudited Standalone and Consolidated financial results of the Company for quarter ended June 30, 2022. Unaudited Standalone and Consolidated financial results of the Company for quarter ended June 30, 2022 (As Per BSE Announcement dated on 26.07.2022)
14-May-2022	25-May-2022	Accounts	Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 inter alia to consider and approve Board Meeting Intimation for approval of Audited Standalone and Consolidated Financial Results for quarter and year ended March 31 2022 and recommendation of dividend for FY 2021-22 Shalby Board recommend dividend of Rs. 1.00 per equity share of Rs. 10.00 Outcome of Board Meeting held on 25-May-2022 to consider Audited Standalone and Consolidated financial statements for the quarter and year ended March 31, 2022 and Dividend (As per BSE Announcement Dated on 25/5/2022)

1 2

LOGIN HERE

Shalby Ltd

Board Meeting